Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ADIL
- Price
- 0.23
- Stock movement up
- +0.01 (5.80%)
- Company name
- Adial Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 6.13M
- Ent value
- 2.68M
- Price/Sales
- 10867.74
- Price/Book
- 1.36
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -49.58%
- 1 year return (CAGR)
- -76.35%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ADIL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 10867.74 |
| Price to Book | 1.36 |
| EV to Sales | 4748.00 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 26.65M |
| EPS (TTM) | -0.36 |
| FCF per share (TTM) | -0.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 564.00 |
| Gross profit (TTM) | -564.00 |
| Operating income (TTM) | -7.85M |
| Net income (TTM) | -8.05M |
| EPS (TTM) | -0.36 |
| EPS (1y forward) | -0.39 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -100.00% |
| Operating margin (TTM) | -214748.36% |
| Profit margin (TTM) | -214748.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.61M |
| Net receivables | 0.00 |
| Total current assets | 5.01M |
| Goodwill | 0.00 |
| Intangible assets | 2.92K |
| Property, plant and equipment | 0.00 |
| Total assets | 5.66M |
| Accounts payable | 556.28K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.15M |
| Total liabilities | 1.15M |
| Shareholder's equity | 4.51M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -6.62M |
| Capital expenditures (TTM) | 6.00 |
| Free cash flow (TTM) | -6.62M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -178.73% |
| Return on Assets | -142.26% |
| Return on Invested Capital | -178.73% |
| Cash Return on Invested Capital | -146.99% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.22 |
| Daily high | 0.23 |
| Daily low | 0.22 |
| Daily Volume | 214K |
| All-time high | 208.25 |
| 1y analyst estimate | 2.17 |
| Beta | 1.11 |
| EPS (TTM) | -0.36 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ADIL | S&P500 | |
| Current price drop from All-time high | -99.89% | -0.89% |
| Highest price drop | -99.90% | -19.00% |
| Date of highest drop | 20 Jan 2026 | 8 Apr 2025 |
| Avg drop from high | -99.71% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
6.13M
Marketcap category
Small-cap
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.
Employees
5
Website
Investor relations
-
SEC filings
CEO
William B. Stilley
Country
USA
City
Charlottesville
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page